Back
Aboitiz Equity Ventures Vs. Collegium Pharmaceutical Industry Stock Comparison
Buy
61
ABTZY
Aboitiz Equity Ventures
Last Price:
8.17
Seasonality Move:
1.28%
Sell
48
COLL
Collegium Pharmaceutical
Last Price:
31.46
Seasonality Move:
-11.42%
Buy
61
Aboitiz Equity Ventures (ABTZY)
is a Buy
Is Aboitiz Equity Ventures a Buy, Sell or Hold?
- The current Aboitiz Equity Ventures [ABTZY] share price is $8.17. The Score for ABTZY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- ABTZY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Collegium Pharmaceutical (COLL)
is a Sell
Is Collegium Pharmaceutical a Buy, Sell or Hold?
- The current Collegium Pharmaceutical [COLL] share price is $32.27. The Score for COLL is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABTZY Stock Price Chart
What is Aboitiz Equity Ventures's stock price today?
-
The Aboitiz Equity Ventures share price today is $8.17
The current trend is relatively stagnant and ABTZY is experiencing slight buying pressure.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $32.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and COLL is experiencing selling pressure, which indicates risk of future bearish movement.
ABTZY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 0 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.17 - 8.17) | Sell |
| Bollinger Bands (100): | (7.98 - 8.48) | Sell |
COLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.89 | Sell |
| Relative Strength Index (14 RSI): | 38.97 | Sell |
| Chaikin Money Flow: | -427201 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.7 - 36.9) | Sell |
| Bollinger Bands (100): | (32.98 - 38) | Sell |
ABTZY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.17 | Sell |
| 20-day SMA: | 8.17 | Sell |
| 50-day SMA: | 8.17 | Sell |
| 200-day SMA: | 8.77 | Sell |
| 8-day EMA: | 8.17 | Sell |
| 20-day EMA: | 8.17 | Sell |
| 50-day EMA: | 8.2 | Sell |
| 200-day EMA: | 8.86 | Sell |
COLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.45 | Sell |
| 20-day SMA: | 34.18 | Sell |
| 50-day SMA: | 36.16 | Sell |
| 200-day SMA: | 30.2 | Buy |
| 8-day EMA: | 33.23 | Sell |
| 20-day EMA: | 34.09 | Sell |
| 50-day EMA: | 35.07 | Sell |
| 200-day EMA: | 31.51 | Buy |
Aboitiz Equity Ventures Earnings Growth & ABTZY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.00 per share, an increase this year of $0.76 per share, and an increase next year of $0.70 per share.
Aboitiz Equity Ventures Technical Analysis
| May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | Jun 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Collegium Pharmaceutical Technical Analysis
| May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | Jun 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||